uniQure N.V. - Ordinary Shares (QURE): Price and Financial Metrics
QURE Price/Volume Stats
| Current price | $16.98 | 52-week high | $17.71 |
| Prev. close | $15.47 | 52-week low | $3.73 |
| Day low | $15.35 | Volume | 2,067,800 |
| Day high | $17.58 | Avg. volume | 1,659,781 |
| 50-day MA | $8.12 | Dividend yield | N/A |
| 200-day MA | $6.24 | Market Cap | 827.66M |
QURE Stock Price Chart Interactive Chart >
uniQure N.V. - Ordinary Shares (QURE) Company Bio
uniQure is a biopharmaceutical company, developing adeno-associated virus (AAV) based gene therapies through its technology platform for multiple therapeutic areas. The company was founded in 1998 and is based in Amsterdam, the Netherlands.
QURE Price Returns
| 1-mo | 190.50% |
| 3-mo | 216.79% |
| 6-mo | 274.01% |
| 1-year | 168.67% |
| 3-year | -21.90% |
| 5-year | -76.36% |
| YTD | 150.81% |
| 2023 | -70.14% |
| 2022 | 9.31% |
| 2021 | -42.60% |
| 2020 | -49.58% |
| 2019 | 148.65% |
Continue Researching QURE
Want to see what other sources are saying about uniQure NV's financials and stock price? Try the links below:uniQure NV (QURE) Stock Price | Nasdaq
uniQure NV (QURE) Stock Quote, History and News - Yahoo Finance
uniQure NV (QURE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...